Same medicine. Same results. ™
GPhA Applauds FDA for Completing Generic Drug User Fee Act Recommendations 1.13.2012
GPhA Names David Gaugh Vice President for Regulatory Sciences 1.10.2012
Ahaviah Glaser Named GPhA VP for Policy and Strategic Alliances 12.08.2011
GPhA Joins Global Pharmaceutical Industry in Mourning the Passing of Former Teva CEO Eli Hurvitz 11.23.2011
GPhA Applauds Congress for Ensuring FDA and OGD Remain Fully Funded in 2012 11.18.2011
GPhA: Ban on Patent Settlements is One Prescription Super Commitee Should Ignore 11.15.2011
GPhA: Projected Savings from Patent Settlement Ban Rely on Faulty Assumptions 11.09.2011
GPhA: Recommendations in PhRMA-Funded Report Would Gut Hatch-Waxman Act 11.07.2011
GPhA Acclaims Hatch-Waxman as Model for Savings; Urges Shortened Exclusivity Period for Biogenerics 11.07.2011
GPhA Commends White House Efforts to Address Drug Shortages 10.31.2011
GPhA Continues Support of National Prescription Drug Take-Back Day 10.28.2011